Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Analysis of Subvisible Particles by Light Obscuration (LO) / Single Particle Optical Sensing (SPOS) (CAT#: STEM-MB-2256-CJ)

Introduction

The quantification and characterization of subvisible particles are important for ensuring the quality and safety of therapeutic protein injections. The subvisible particles may consist of rubber from stoppers, glass from containers, filter materials, silicone oil droplets from syringes, and aggregated protein particles. To date, the importance of measuring subvisible particles in therapeutic protein injections has increased as the protein aggregates could elicit not only a decrease of the therapeutic efficacy but also adverse immunogenic reactions. Protein molecules are likely to be adsorbed onto multiple interfaces, such as air-liquid, vial-liquid, and liquid-liquid in vials or syringes. The adsorption of protein molecules to these interfaces results in a conformational change, leading to denaturation, and finally to aggregation. Moreover, therapeutic proteins undergo numerous stresses, such as ultraviolet-light, agitation, and heat during the processes of production, storage, and shipment. These stresses could also generate subvisible particles in therapeutic protein injections.




Principle

Light obscuration is an analytical technique in which the individual particles in a liquid suspension are placed in-between a laser light source and a detector. The laser light source is used to illuminate the individual particles resulting in a shadow or a blockage of light. This shadow or blockage is often called “obscuration”, which is how this particular analytical technique was granted its name. Light obscuration or the reduction of light intensity is measured by the detector. The detector will then process the measured signal and use it to display a comprehensive calibration curve. This curve is then read to quantify particles and determine their size.

Applications

Biomedical; Biopharmaceuticals; Pharmaceutical

Procedure

1. Prepare samples.
2. Dilute sample preparation, more concentrated preparations may require substantial dilution.
3. Operate the instrument according to the manual.
4. Analyze data on imaging particle analysis system.

Materials

• Sample: Particle-based APIs (e.g., VLPs, liposomes, polymeric nanoparticles); Virus Particle; Protein-based Formulations; Sterile Preparations.
• Equipment: Particle Counter Machine.
• Imaging Particle Analysis System.

Notes

1. Light obscuration (LO) is the most widely used subvisible particle assay in the pharmaceutical industry and is the preferred compendial method (USP, EP, JP).
2. LO allows counting and sizing of subvisible particles in the size range from about 1 to 200 µm.
3. Light obscuration (LO) do not need for extra chemicals or consumables
4. When using a light obscuration particle counter, the sample must be presented in a dilute form for analysis.